Zymeworks Inc (ZYME)
NASDAQ:ZYME
Total Valuation
Zymeworks has a market cap or net worth of $1.80B. The enterprise value is $1.77B.
Market Cap$1.80B
Enterprise Value$1.77B
Share Statistics
Zymeworks has 73,749,600 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding73,749,600
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Zymeworks’s return on equity (ROE) is -0.30 and return on invested capital (ROIC) is -30.08%.
Return on Equity (ROE)-0.30
Return on Assets (ROA)-0.23
Return on Invested Capital (ROIC)-30.08%
Return on Capital Employed (ROCE)-0.30
Revenue Per Employee354.40K
Profits Per Employee-271.34K
Employee Count299
Asset Turnover0.31
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Zymeworks is ―. Zymeworks’s PEG ratio is 0.73.
PE Ratio―
PS Ratio18.72
PB Ratio7.39
Price to Fair Value7.39
Price to FCF-57.45
Price to Operating Cash Flow-55.66
PEG Ratio0.73
Income Statement
In the last 12 months, Zymeworks had revenue of 105.97M and earned -81.13M in profits. Earnings per share was -1.08.
Revenue105.97M
Gross Profit95.17M
Operating Income-92.55M
Pretax Income-79.75M
Net Income-81.13M
EBITDA7.65B
Earnings Per Share (EPS)-1.08
Cash Flow
In the last 12 months, operating cash flow was -32.73M and capital expenditures -2.20M, giving a free cash flow of -34.93M billion.
Operating Cash Flow-32.73M
Free Cash Flow-34.93M
Free Cash Flow per Share-0.47
Dividends & Yields
Zymeworks pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.05
52-Week Price Change103.02%
50-Day Moving Average23.51
200-Day Moving Average19.29
Relative Strength Index (RSI)55.56
Average Volume (3m)680.23K
Important Dates
Zymeworks upcoming earnings date is May 6, 2026, Before Open (Confirmed).
Last Earnings DateMar 2, 2026
Next Earnings DateMay 6, 2026
Ex-Dividend Date―
Financial Position
Zymeworks as a current ratio of 5.52, with Debt / Equity ratio of 6.80%
Current Ratio5.52
Quick Ratio5.52
Debt to Market Cap<0.01
Net Debt to EBITDA>-0.01
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Zymeworks has paid 1.38M in taxes.
Income Tax1.38M
Effective Tax Rate-0.02
Enterprise Valuation
Zymeworks EV to EBITDA ratio is 0.26, with an EV/FCF ratio of -56.79.
EV to Sales18.50
EV to EBITDA0.26
EV to Free Cash Flow-56.79
EV to Operating Cash Flow-59.41
Balance Sheet
Zymeworks has $228.80M in cash and marketable securities with $18.27M in debt, giving a net cash position of $210.53M billion.
Cash & Marketable Securities$228.80M
Total Debt$18.27M
Net Cash$210.53M
Net Cash Per Share$2.85
Tangible Book Value Per Share-$173.85
Margins
Gross margin is 98.40%, with operating margin of -87.34%, and net profit margin of -76.56%.
Gross Margin98.40%
Operating Margin-87.34%
Pretax Margin-75.26%
Net Profit Margin-76.56%
EBITDA Margin7214.88%
EBIT Margin-75.26%
Analyst Forecast
The average price target for Zymeworks is $39.75, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$39.75
Price Target Upside64.39% Upside
Analyst ConsensusStrong Buy
Analyst Count9
Revenue Growth Forecast116.21%
EPS Growth Forecast43.93%